Antiangiogenic Therapy for High-Grade Gliomas

E-ISSN： 1996-3181|8|3|184-194

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.8, Iss.3, 2009-07, pp. : 184-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carmustine implants costly in high-grade gliomas

Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Approaches to Improve Efficiency of Dendritic Cell-based Therapy of High Grade Gliomas

Current Pharmaceutical Design, Vol. 22, Iss. 37, 2016-11 ,pp. : 5738-5751

Bentham Science Publishers

Access to resources Recommend Favorite

Chemotherapy and Target Therapy in the Management of Adult High- Grade Gliomas

Current Cancer Drug Targets, Vol. 12, Iss. 8, 2012-10 ,pp. : 1016-1031

Bentham Science Publishers

Access to resources Recommend Favorite

Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas: A Cost-Utility Analysis

By Rogers Gabriel Garside Ruth Mealing Stuart Pitt Martin Anderson Rob Dyer Matthew Stein Ken Somerville Margaret

PharmacoEconomics, Vol. 26, Iss. 1, 2008-01 ,pp. : 33-44

Adis International

Access to resources Recommend Favorite

Chemoresistance in High-Grade Gliomas: Relevance of Adenosine Signalling in Stem-Like Cells of Glioblastoma Multiforme

Current Drug Targets, Vol. 15, Iss. 10, 2014-09 ,pp. : 931-942

Bentham Science Publishers

Access to resources Recommend Favorite